Open AccessErythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients
Author(s) -
Robert N. Foley,
Bryan M. Curtis,
Patrick S. Parfrey
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04950908
Subject(s) - medicine , hemodialysis , erythropoietin , epoetin alfa , quality of life (healthcare) , dialysis , kidney disease , anemia , hemoglobin , body mass index , population , surgery , nursing , environmental health
The effects of different hemoglobin targets when using erythropoiesis-stimulating agents on quality of life are somewhat controversial, and predictors of change in quality of life in endstage renal disease have not been well characterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom